Aequus Pharmaceuticals Inc. AQSZF

Set alert

Price alert · AQSZF

All alert types
0.00 USD 0.00 0.00%

At close · Oct 30

0.0007 Day range 0.0007
0.0002 52-week range 0.008
YTD
-85.00%
1 year
-85.71%
Open
0.0007
Prev close
0.0003
Mkt cap
39.79K
Vol
694.09K
Avg vol
31.24K
EPS
-0.01
P/E
0.00
More statistics
Low
0.0007
High
0.0007

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for AQSZF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-297.95 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.3×
FY 2015: -4.0×FY 2016: -2.4×FY 2017: -6.1×FY 2018: -4.2×FY 2019: -3.1×FY 2020: -9.8×FY 2021: -8.1×FY 2022: -1.3×FY 2023: -1.3×FY 2024: -0.3×
FY 2015 5y median -1.3× FY 2024
P/S 1.3×
FY 2015: 0.0×FY 2016: 16.0×FY 2017: 20.9×FY 2018: 8.3×FY 2019: 6.0×FY 2020: 4.0×FY 2021: 5.4×FY 2022: 3.0×FY 2023: 14.7×FY 2024: 1.3×
FY 2015 5y median 4.0× FY 2024
P/B -0.1×
FY 2015: 16.3×FY 2016: 8.9×FY 2017: 10.3×FY 2018: 6.9×FY 2019: -11.1×FY 2020: 17.9×FY 2021: 8.2×FY 2022: -3.0×FY 2023: -0.9×FY 2024: -0.1×
FY 2015 5y median -0.1× FY 2024
P/FCF -0.4×
FY 2015: -5.1×FY 2016: -2.3×FY 2017: -6.2×FY 2018: -4.5×FY 2019: -6.0×FY 2020: -12.6×FY 2021: -12.5×FY 2022: -2.2×FY 2023: -1.6×FY 2024: -0.4×
FY 2015 5y median -2.2× FY 2024
EV/EBITDA -4.1×
FY 2015: -4.0×FY 2016: -2.3×FY 2017: -6.0×FY 2018: -4.3×FY 2019: -5.1×FY 2020: -34.5×FY 2021: -11.8×FY 2022: -2.4×FY 2023: -3.2×FY 2024: -4.1×
FY 2015 5y median -4.1× FY 2024
EV/Sales 12.5×
FY 2015: 0.0×FY 2016: 15.3×FY 2017: 19.8×FY 2018: 8.0×FY 2019: 7.0×FY 2020: 4.2×FY 2021: 5.3×FY 2022: 4.9×FY 2023: 33.9×FY 2024: 12.5×
FY 2015 5y median 5.3× FY 2024
FCF Yield -222.6%
FY 2015: -19.5%FY 2016: -44.1%FY 2017: -16.2%FY 2018: -22.2%FY 2019: -16.8%FY 2020: -8.0%FY 2021: -8.0%FY 2022: -46.5%FY 2023: -61.1%FY 2024: -222.6%
FY 2015 5y median -46.5% FY 2024

Profitability

Gross Margin 56.9%
FY 2015: 0.0%FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 98.4%FY 2022: 83.1%FY 2023: 56.4%FY 2024: 56.9%
FY 2015 5y median 83.1% FY 2024
Operating Margin -364.1%
FY 2015: 0.0%FY 2016: 693.2%FY 2017: -344.9%FY 2018: -199.0%FY 2019: -135.3%FY 2020: -30.1%FY 2021: -59.2%FY 2022: -187.2%FY 2023: -1106.4%FY 2024: -364.1%
FY 2015 5y median -187.2% FY 2024
Net Margin -372.7%
FY 2015: 0.0%FY 2016: -685.8%FY 2017: -340.7%FY 2018: -198.8%FY 2019: -190.3%FY 2020: -40.3%FY 2021: -66.7%FY 2022: -232.7%FY 2023: -1163.1%FY 2024: -372.7%
FY 2015 5y median -232.7% FY 2024
ROE 33.7%
FY 2015: -390.1%FY 2016: -380.2%FY 2017: -168.4%FY 2018: -166.7%FY 2019: 354.1%FY 2020: -182.1%FY 2021: -101.1%FY 2022: 232.6%FY 2023: 69.0%FY 2024: 33.7%
FY 2015 5y median 33.7% FY 2024
ROIC -1350.6%
FY 2015: 390.1%FY 2016: 380.3%FY 2017: -169.2%FY 2018: -166.7%FY 2019: -164.8%FY 2020: -26.9%FY 2021: -40.5%FY 2022: -184.1%FY 2023: -366.3%FY 2024: -1350.6%
FY 2015 5y median -184.1% FY 2024
ROA -272.1%
FY 2015: -206.3%FY 2016: -239.4%FY 2017: -145.3%FY 2018: -140.4%FY 2019: -185.7%FY 2020: -33.3%FY 2021: -41.6%FY 2022: -189.8%FY 2023: -272.9%FY 2024: -272.1%
FY 2015 5y median -189.8% FY 2024

Growth (YoY)

Revenue 129.2%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 62.4%FY 2018: 23.8%FY 2019: 15.8%FY 2020: 58.8%FY 2021: 4.7%FY 2022: -49.2%FY 2023: -81.5%FY 2024: 129.2%
FY 2015 FY 2024
Operating Income 24.6%
FY 2015: 104.1%FY 2016: -3.8%FY 2017: -180.8%FY 2018: 28.6%FY 2019: 21.3%FY 2020: 64.7%FY 2021: -106.1%FY 2022: -60.7%FY 2023: -9.2%FY 2024: 24.6%
FY 2015 FY 2024
EPS (diluted) 26.8%
FY 2015: -55.6%FY 2016: 33.3%FY 2017: 42.8%FY 2018: 35.1%FY 2019: -4.0%FY 2020: 71.0%FY 2021: -25.0%FY 2022: -72.9%FY 2023: 7.4%FY 2024: 26.8%
FY 2015 FY 2024
Free Cash Flow 27.8%
FY 2015: -199.0%FY 2016: -21.1%FY 2017: 21.9%FY 2018: 33.0%FY 2019: 36.9%FY 2020: 49.9%FY 2021: -43.9%FY 2022: -66.0%FY 2023: -17.5%FY 2024: 27.8%
FY 2015 FY 2024

Financial Health

Current Ratio 0.0×
FY 2015: 1.2×FY 2016: 1.1×FY 2017: 4.7×FY 2018: 3.9×FY 2019: 2.3×FY 2020: 7.2×FY 2021: 1.5×FY 2022: 0.4×FY 2023: 0.1×FY 2024: 0.0×
FY 2015 5y median 0.4× FY 2024
Quick Ratio 0.0×
FY 2015: 1.1×FY 2016: 1.1×FY 2017: 4.7×FY 2018: 3.9×FY 2019: 2.3×FY 2020: 6.9×FY 2021: 1.4×FY 2022: 0.3×FY 2023: 0.1×FY 2024: 0.0×
FY 2015 5y median 0.3× FY 2024
Debt / Equity -1.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -2.5×FY 2020: 4.0×FY 2021: 1.2×FY 2022: -2.0×FY 2023: -1.2×FY 2024: -1.0×
FY 2015 5y median -1.0× FY 2024
Net Debt / EBITDA -3.7×
FY 2015: 0.2×FY 2016: 0.1×FY 2017: 0.3×FY 2018: 0.1×FY 2019: -0.8×FY 2020: -1.9×FY 2021: 0.2×FY 2022: -0.9×FY 2023: -1.8×FY 2024: -3.7×
FY 2015 5y median -1.8× FY 2024
Interest Coverage -8.4×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -5.3×FY 2020: -1.5×FY 2021: -3.5×FY 2022: -12.1×FY 2023: -19.4×FY 2024: -8.4×
FY 2015 5y median -8.4× FY 2024

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31